Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients

Autor: Emma J. Kooistra, Miranda van Berkel, Noortje F. van Kempen, Celine R. M. van Latum, Niklas Bruse, Tim Frenzel, Maarten J. W. van den Berg, Jeroen A. Schouten, Matthijs Kox, Peter Pickkers

Publikováno v: Critical Care, Vol 25, Iss 1, Pp 1-12 (2021)

Abstract Background Procalcitonin (PCT) and C-reactive protein (CRP) were previously shown to have value for the detection of secondary infections in critically ill COVID-19 patients. However, since the introduction of immunomodulatory therapy, the v

Externí odkaz: https://doaj.org/article/d748f12da5204041871e3f5c1ec28db4

A Discolored Neonate Causes Interference in Laboratory Test Results

Autor: Lonneke Aarts, Miranda van Berkel, Tessa Ribbers, Roxana Rassouli-Kirchmeier

Publikováno v: Journal of Applied Laboratory Medicine, 6, 4, pp. 1051-1056
Journal of Applied Laboratory Medicine, 6, 1051-1056

Contains fulltext : 236716.pdf (Publisher’s version ) (Closed access)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c26ee8e0b5fa7a117bd3b2ac660d927
https://doi.org/10.1093/jalm/jfaa240

SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes

Autor: Mark H.H. Kramer, Adrian Post, Ele Ferrannini, Marcel H.A. Muskiet, Erik J.M. van Bommel, Daniël H. van Raalte, Daan J Touw, Stephan J. L. Bakker, Max Nieuwdorp, Jaap A. Joles, Frank Geurts, Miranda van Berkel, Ewout J. Hoorn, A.H. Jan Danser

Publikováno v: Clinical science (London, England, 134(23), 3107-3118. Portland Press Ltd.
Clinical Science, 134(23), 3107-3118. Portland Press, Ltd.
Clinical Science, 134, 23, pp. 3107-3118
Clinical science (London, England : 1979), 134(23), 3107-3118
Clinical Science, 134, 3107-3118
van Bommel, E J M, Geurts, F, Muskiet, M H A, Post, A, Bakker, S J L, Danser, A H J, Touw, D J, van Berkel, M, Kramer, M H H, Nieuwdorp, M, Ferrannini, E, Joles, J A, Hoorn, E J & van Raalte, D H 2020, ' SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes ', Clinical science (London, England : 1979), vol. 134, no. 23, pp. 3107-3118 . https://doi.org/10.1042/CS20201274
Clinical Science, 134(23), 3107-3118. PORTLAND PRESS LTD

Sodium–glucose transporter (SGLT)2 inhibitors increase plasma magnesium and plasma phosphate and may cause ketoacidosis, but the contribution of improved glycemic control to these observations as well as effects on other electrolytes and acid–bas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3e88f7b816c8cec80fdf1b78fab60ac
https://doi.org/10.1042/cs20201274

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients

Autor: Celine R. M. van Latum, Jeroen Schouten, Matthijs Kox, Noortje F. van Kempen, Tim Frenzel, Peter Pickkers, Emma J. Kooistra, Maarten van den Berg, Niklas Bruse, Miranda van Berkel

Publikováno v: Critical Care
Critical Care, 25
Critical Care, Vol 25, Iss 1, Pp 1-12 (2021)
Critical Care, 25, 1

BackgroundProcalcitonin (PCT) and C-reactive protein (CRP) were previously shown to have value for the detection of secondary infections in critically ill COVID-19 patients. However, since the introduction of immunomodulatory therapy, the value of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61fde6392da5ea4c9f0ec0f3b5ed21d1
http://europepmc.org/articles/PMC8340482

Diagnosis of acute myocardial infarction in hemodialysis patients may be feasible by comparing variation of cardiac troponins during acute presentation to baseline variation

Autor: Marijke J E Dekker, Miranda van Berkel, Hanneke Bogers, Daniël A. Geerse, Constantijn J.A.M. Konings, Volkher Scharnhorst

Publikováno v: Clinica Chimica Acta, 456, pp. 36-41
Clinica Chimica Acta, 456, 36-41. Elsevier
Clinica Chimica Acta, 456, 36-41

Acute myocardial infarction (AMI) is defined as a dynamic change in cardiac troponin (cTn) with at least one cTn value exceeding the 99th percentile of a reference population in combination with typical clinical symptoms. In hemodialysis (HD) patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6695e61361ae5ecffa3d0f1686f7a9e1
https://doi.org/10.1016/j.cca.2016.01.022